Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
22.98
Nov 20 • 3:59 PM ET Dollar change-0.28 Percentage change(-1.20%)
Aftermarket Close
22.98
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
187.84M
Enterprise Value
171.96M
Income
11.93M
Sales
75.57M
Book/sh
6.37
Cash/sh
1.94
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
197
IPO
Aug 13, 2010
P/E
16.78
Forward P/E
13.68
PEG
0.80
P/S
2.49
P/B
3.61
P/C
11.83
P/FCF
21.59
EV/EBITDA
10.90
EV/Sales
2.28
Quick Ratio
6.66
Current Ratio
7.19
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
1.37
EPS next Y
1.68
EPS next Q
0.35
EPS this Y
13.46%
EPS next Y
13.90%
EPS next 5Y
17.15%
EPS past 3/5Y
52.90% 37.46%
Sales past 3/5Y
15.35% 15.59%
EPS Y/Y TTM
47.72%
Sales Y/Y TTM
14.12%
EPS Q/Q
28.09%
Sales Q/Q
10.63%
Insider Own
17.21%
Insider Trans
-1.51%
Inst Own
63.08%
Inst Trans
3.14%
ROA
20.79%
ROE
24.53%
ROIC
22.73%
Gross Margin
78.98%
Oper. Margin
19.45%
Profit Margin
15.78%
SMA20
-10.77%
SMA50
-14.28%
SMA200
-25.93%
Trades
Shs Outstand
8.24M
Shs Float
6.77M
52W High
47.40 -51.52%
52W Low
22.67 1.37%
Volatility
4.70% 4.57%
ATR (14)
1.13
RSI (14)
26.93
Beta
0.51
Rel Volume
0.96
Avg Volume
84.14K
Volume
80,805
Perf Week
-5.51%
Perf Month
-14.48%
Perf Quarter
-42.96%
Perf Half Y
-39.87%
Perf YTD
-21.09%
Perf Year
-8.45%
Perf 3Y
123.11%
Perf 5Y
94.91%
Perf 10Y
409.53%
Prev Close
23.26
Price
22.98
Change %
-1.20%
Consensus
Strong Buy
Avg. Price Target
$48.50
Implied Upside
+111.1%
Analysts5incl. previous ratings
Rating Distribution5 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 27, 2025Resumed
LLake Street
Buy$36+56.7%
Jul 22, 2025Initiated
RRoth Capital
Buy$29+26.2%
Feb 20, 2025Initiated
RILY logoRB. Riley Securities
Buy$38+65.4%
Oct 18, 2019Initiated
DDougherty & Company
Buy$12-47.8%
Dec 31, 2013Reiterated
FFeltl & Co.
Buy$1.80 → $2.75-88.0%
Oct 19, 2010Initiated
FFeltl & Co.
Buy$5-78.2%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cunniff James L.CEO and PresidentJun 08 '26Option Exercise17.259,700167,325157,451Jun 09 05:12 PM
Cunniff James L.CEO and PresidentJun 08 '26Sale36.509,700354,095147,751Jun 09 05:12 PM
Nagel Bradley M.Chief Financial OfficerJun 04 '26Option Exercise10.509,601100,83331,439Jun 08 07:39 PM
Nagel Bradley M.Chief Financial OfficerJun 04 '26Sale36.3511,801428,93619,638Jun 08 07:39 PM
Cunniff James L.OfficerJun 08 '26Proposed Sale36.509,700354,095Jun 08 01:19 PM
Nagel Bradley M.OfficerJun 04 '26Proposed Sale36.3511,801428,937Jun 04 03:50 PM
SKARVAN KATHLEENDirectorMay 15 '26Option Exercise3.8240,000152,80075,622May 19 04:44 PM
SKARVAN KATHLEENDirectorMay 15 '26Sale35.4840,0001,419,35835,622May 19 04:44 PM
SKARVAN KATHLEENDirectorMay 15 '26Proposed Sale35.4840,0001,419,358May 15 04:25 PM
Electromed, Inc. engages in the development, manufacturing, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.
PresidentMr. James L. Cunniff
CFOMr. Bradley M. Nagel